<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02756312</url>
  </required_header>
  <id_info>
    <org_study_id>ChiECRCT-20200049</org_study_id>
    <nct_id>NCT02756312</nct_id>
  </id_info>
  <brief_title>The Impact of Anesthesia on High- Grade Glioma Patients</brief_title>
  <official_title>The Impact of Anesthesia on the Outcome of Supratentorial High- Grade Glioma Patients After Craniotomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Tiantan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Tiantan Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Although bench data and retrospective studies have provided a promising picture of the&#xD;
      possible influence of anesthetic technique on the risk of tumor progression and patients&#xD;
      mortality, current evidence from RCTs is inadequate to show whether the type of anesthetics&#xD;
      might influence tumor progression and patient survival.There are many thousands of patients&#xD;
      with a cancer diagnosis undergoing surgery every year, and in the context of biological&#xD;
      plausibility, it should lead to the urgent undertaking of RCTs to further evaluate the&#xD;
      association between the anesthetic management and patient outcome.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Although bench data and retrospective studies have provided a promising picture of the&#xD;
      possible influence of anesthetic technique on the risk of tumor progression and patient&#xD;
      mortality, current evidence from RCTs is inadequate to show whether the type of anesthetics&#xD;
      might influence the outcome of the patients.There are many thousands of patients with a&#xD;
      cancer diagnosis undergoing surgery every year, and in the context of biological&#xD;
      plausibility, it should lead to the urgent undertaking of RCTs to further evaluate the&#xD;
      association between the anesthetic management and patient outcome.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>This is a single centre, randomized, parallel group controlled clinical trial in patients with primary HGG. All eligible patients will be 1:1 randomized to the TIVA or INHA group. The object of the trail is to evaluate the effect of propofol or sevoflurane on the prognosis of supratentorial HGG patients after craniotomy.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>The anesthesiologist know the grouping .The subjects and the outcome assesor trained for telephone visit were blinded to the grouping</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>overall survival in18 months</measure>
    <time_frame>Postoperative 18 months</time_frame>
    <description>overall survival in18 months</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">196</enrollment>
  <condition>Anesthesia, Outcome, High-grade Glioma</condition>
  <arm_group>
    <arm_group_label>Intravenous anesthesia</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients will receive total intravenous anesthesia undergoing brain tumor resection.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Inhalation anesthesia</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients will receive volatile inhalational anesthesia undergoing brain tumor resection.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>IV Anesthesia</intervention_name>
    <description>The patients will receive intravenous anesthesia</description>
    <arm_group_label>Intravenous anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>IH anesthesia</intervention_name>
    <description>The patients will receive inhalation anesthesia</description>
    <arm_group_label>Inhalation anesthesia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        1)Magnetic radiology imaging diagnosis of supratentorial high-grade glioma; 2) Patients&#xD;
        undergoing tumor resection under selective general anesthesia; 3) Age 18-80 years old; 4)&#xD;
        Preoperative KPS &lt; 80; 5) With written informed consent by patients or their relatives.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        1) History of other operations before; 2) Patients with recurrence and metastasis of&#xD;
        gliomas or with malignant tumors of other organs; 3) Emergency operation; 4) Critical&#xD;
        condition (ASA grade â‰¥ V before operation, Appendix 1, Severe liver and kidney dysfunction;&#xD;
        5) Patients with mental illness, severe dementia, language disorder, coma, and end-stage&#xD;
        disease, etc.; 6) Pregnant or breastfeeding women; 7) Allergic to study drugs;8) Patients&#xD;
        who need electrophysiological monitoring during operation. 9) Patients receiving&#xD;
        reoperation with different anesthesia methods will be removed and the patients with the&#xD;
        same anesthesia method will be continued to observe; 10) Postoperative pathological result&#xD;
        is not high-grade glioma.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yuming Peng, M.D., Ph.D.</last_name>
    <phone>8610-59976656</phone>
    <email>florapym766@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Beijing Tiantan Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100070</zip>
        <country>China</country>
      </address>
    </facility>
    <contact>
      <last_name>Yuming Peng</last_name>
    </contact>
    <contact_backup>
      <last_name>Jia Dong</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>April 27, 2016</study_first_submitted>
  <study_first_submitted_qc>April 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 29, 2016</study_first_posted>
  <last_update_submitted>September 6, 2020</last_update_submitted>
  <last_update_submitted_qc>September 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Tiantan Hospital</investigator_affiliation>
    <investigator_full_name>Yuming Peng</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glioma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

